Angiotensin Receptor Blockers Linked to Reduced Risk of New-Onset Epilepsy in Hypertensive Patients: Study Medha Baranwal26 Jun 2024 10:00 AM ISTUSA: Recent medical research has sparked interest in the potential link between angiotensin receptor blockers (ARBs), commonly prescribed for...
Cyclic neutropenia and concomitant IgA nephropathy: a case report Dr. Shravani Dali7 May 2023 8:00 PM ISTResearchers have reported a case of Cyclic neutropenia and concomitant IgA nephropathy that has been published in the BMC Nephrology.IgA nephropathy...
Oral combined lisinopril and hydrochlorothiazide superior to nifedipine for BP control in postpartum hypertension Medha Baranwal6 March 2023 10:45 AM ISTUSA: Combined hydrochlorothiazide and lisinopril therapy give superior short-term BP (blood pressure) control for postpartum hypertension versus...
Combo of SGLT2 and ACE inhibitors reduces risk of cardiorenal complications: Circulation Medha Baranwal7 Dec 2022 7:30 PM ISTEmpagliflozin addition to ramipril, betters surrogate measures of kidney protection in patients with uncomplicated type 1 diabetes and preserved...
Patiromer Improves Potassium Levels in CKD patients with HFrEF: DIAMOND Trial MD Bureau13 April 2022 9:30 AM ISTRenin-angiotensin-aldosterone system inhibitors (RAASi) are the cornerstone of treatment for both heart failure with reduced ejection fraction (HFrEF)...
Evidence-based review on the incidence of ACEIs induced cough published in Indian Heart Journal Dr. Prem Aggarwal16 Sept 2020 11:45 AM ISTNew Delhi: Angiotensin-converting enzyme inhibitors (ACEIs) are most often prescribed as the first-line treatment modality in hypertensive patients....
ACEIs and ARBs may improve prognosis of high BP patients with COVID-19, finds review Dr. Kamal Kant Kohli31 March 2020 8:24 AM ISTRochester, MN, - Researchers after reviewing studies have concluded that ACEIs and ARBs, may have a role to play in the treatment of COVID-19 and may...
